Login to Your Account



Other News To Note


Tuesday, September 4, 2012
• Cell Therapeutics Inc., of Seattle, said that it filed with the secretary of state for the State of Washington an amendment to its amended and restated articles of incorporation to implement a 1-for-5 reverse stock. CTI's total number of authorized shares will be decreased from 384,999,999 shares to 76,999,999 shares.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription